BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32234046)

  • 1. Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis.
    Dornquast C; Dombrowski M; Zabel M; Willich SN; Reinhold T
    BMC Health Serv Res; 2020 Mar; 20(1):271. PubMed ID: 32234046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
    Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
    PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
    Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
    Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential drug-drug interactions in older adults: A population-based study.
    Santos TRA; Silveira EA; Pereira LV; Provin MP; Lima DM; Amaral RG
    Geriatr Gerontol Int; 2017 Dec; 17(12):2336-2346. PubMed ID: 28635169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-disease interaction in elderly patients in family practice.
    Mand P; Roth K; Biertz F; Kersting M; Kruschinski C; Schmiemann G; Hummers-Pradier E
    Int J Clin Pharmacol Ther; 2014 May; 52(5):337-45. PubMed ID: 24691059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
    Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
    Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported medication in community-dwelling older adults in Germany: results from the Berlin Initiative Study.
    Mielke N; Huscher D; Douros A; Ebert N; Gaedeke J; van der Giet M; Kuhlmann MK; Martus P; Schaeffner E
    BMC Geriatr; 2020 Jan; 20(1):22. PubMed ID: 31964342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential drug-drug interaction and its determinants among patients with cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an institutional-based cross-sectional study.
    Wondm SA; Tamene FB; Gubae K; Dagnew SB; Worku AA; Belachew EA
    BMJ Open; 2023 Dec; 13(12):e077863. PubMed ID: 38070913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.
    Feinstein J; Dai D; Zhong W; Freedman J; Feudtner C
    Pediatrics; 2015 Jan; 135(1):e99-108. PubMed ID: 25511114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients.
    Tseng A; Szadkowski L; Walmsley S; Salit I; Raboud J
    Ann Pharmacother; 2013 Nov; 47(11):1429-39. PubMed ID: 24285760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
    Shouqair TM; Rabbani SA; Sridhar SB; Kurian MT
    Cureus; 2022 Apr; 14(4):e24019. PubMed ID: 35573572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis.
    Debus JL; Bachmann P; Frahm N; Mashhadiakbar P; Langhorst SE; Streckenbach B; Baldt J; Heidler F; Hecker M; Zettl UK
    Ther Adv Chronic Dis; 2022; 13():20406223221108391. PubMed ID: 35959503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
    Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
    Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Polypharmacy and Its Outcome in Terms of Drug Interaction in an Elderly Population: A Retrospective Cross-Sectional Study.
    Alhumaidi RM; Bamagous GA; Alsanosi SM; Alqashqari HS; Qadhi RS; Alhindi YZ; Ayoub N; Falemban AH
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders.
    Wolff J; Reißner P; Hefner G; Normann C; Kaier K; Binder H; Hiemke C; Toto S; Domschke K; Marschollek M; Klimke A
    PLoS One; 2021; 16(7):e0255192. PubMed ID: 34293068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment.
    Schneider KL; Kastenmüller K; Weckbecker K; Bleckwenn M; Böhme M; Stingl JC
    Drugs Aging; 2018 Jun; 35(6):559-568. PubMed ID: 29737468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology.
    Pirnejad H; Amiri P; Niazkhani Z; Shiva A; Makhdoomi K; Abkhiz S; van der Sijs H; Bal R
    Int J Med Inform; 2019 Jul; 127():18-26. PubMed ID: 31128828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence of Drug-Drug Interactions with Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in the Intensive Care Unit.
    Johnston JP; Heavner MS; Liu M; Casal GLH; Akgün KM
    J Pharm Pract; 2023 Apr; 36(2):322-328. PubMed ID: 34587846
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases.
    Hecker M; Frahm N; Bachmann P; Debus JL; Haker MC; Mashhadiakbar P; Langhorst SE; Baldt J; Streckenbach B; Heidler F; Zettl UK
    Front Pharmacol; 2022; 13():946351. PubMed ID: 36034780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.